These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 33982858)

  • 21. Association of Maternal Use of Triptans During Pregnancy With Risk of Attention-Deficit/Hyperactivity Disorder in Offspring.
    Harris GM; Wood M; Ystrom E; Nordeng H
    JAMA Netw Open; 2022 Jun; 5(6):e2215333. PubMed ID: 35657626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Time-Dependent Selective Serotonin Reuptake Inhibitor Antidepressants During Pregnancy on Behavioral, Emotional, and Social Development in Preschool-Aged Children.
    Lupattelli A; Wood M; Ystrom E; Skurtveit S; Handal M; Nordeng H
    J Am Acad Child Adolesc Psychiatry; 2018 Mar; 57(3):200-208. PubMed ID: 29496129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder, and Attention-Deficit/Hyperactivity Disorder in Offspring.
    Sujan AC; Rickert ME; Öberg AS; Quinn PD; Hernández-Díaz S; Almqvist C; Lichtenstein P; Larsson H; D'Onofrio BM
    JAMA; 2017 Apr; 317(15):1553-1562. PubMed ID: 28418479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age.
    Wang Z; Chan AYL; Coghill D; Ip P; Lau WCY; Simonoff E; Brauer R; Wei L; Wong ICK; Man KKC
    JAMA Intern Med; 2021 Oct; 181(10):1332-1340. PubMed ID: 34398171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children.
    Boukhris T; Sheehy O; Mottron L; Bérard A
    JAMA Pediatr; 2016 Feb; 170(2):117-24. PubMed ID: 26660917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) During Pregnancy and the Risk for Autism spectrum disorder (ASD) and Attention deficit hyperactivity disorder (ADHD) in the Offspring: A True Effect or a Bias? A Systematic Review & Meta-Analysis.
    Leshem R; Bar-Oz B; Diav-Citrin O; Gbaly S; Soliman J; Renoux C; Matok I
    Curr Neuropharmacol; 2021; 19(6):896-906. PubMed ID: 33655866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prenatal antidepressant exposure and child behavioural outcomes at 7 years of age: a study within the Danish National Birth Cohort.
    Grzeskowiak LE; Morrison JL; Henriksen TB; Bech BH; Obel C; Olsen J; Pedersen LH
    BJOG; 2016 Nov; 123(12):1919-1928. PubMed ID: 26374344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregnancy exposure to organophosphate esters and the risk of attention-deficit hyperactivity disorder in the Norwegian mother, father and child cohort study.
    Choi G; Keil AP; Richardson DB; Daniels JL; Hoffman K; Villanger GD; Sakhi AK; Thomsen C; Reichborn-Kjennerud T; Aase H; Engel SM
    Environ Int; 2021 Sep; 154():106549. PubMed ID: 33910116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age.
    Oberlander TF; Papsdorf M; Brain UM; Misri S; Ross C; Grunau RE
    Arch Pediatr Adolesc Med; 2010 May; 164(5):444-51. PubMed ID: 20439795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn.
    Bérard A; Sheehy O; Zhao JP; Vinet É; Bernatsky S; Abrahamowicz M
    Br J Clin Pharmacol; 2017 May; 83(5):1126-1133. PubMed ID: 27874994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
    Bérard A; Zhao JP; Sheehy O
    BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age.
    Grzeskowiak LE; Gilbert AL; Sørensen TI; Olsen J; Sørensen HT; Pedersen LH; Morrison JL
    Ann Epidemiol; 2013 Nov; 23(11):681-7. PubMed ID: 24113367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal Antidepressant Use During Pregnancy and the Risk of Attention-Deficit/Hyperactivity Disorder in Children: A Systematic Review of the Current Literature.
    Uguz F
    J Clin Psychopharmacol; 2018 Jun; 38(3):254-259. PubMed ID: 29596147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
    Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
    CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations Between Brain Structure and Connectivity in Infants and Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy.
    Lugo-Candelas C; Cha J; Hong S; Bastidas V; Weissman M; Fifer WP; Myers M; Talati A; Bansal R; Peterson BS; Monk C; Gingrich JA; Posner J
    JAMA Pediatr; 2018 Jun; 172(6):525-533. PubMed ID: 29630692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal SSRI use during pregnancy and offspring depression or anxiety disorders: A review of the literature and description of a study protocol for a register-based cohort study.
    Upadhyaya S; Brown A; Cheslack-Postava K; Gissler M; Gyllenberg D; Heinonen E; Laitinen J; McKeague I; Hinkka-Yli-Salomäki S; Sourander A; Tornio A; Malm H
    Reprod Toxicol; 2023 Jun; 118():108365. PubMed ID: 36958464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Risk for Attention-Deficit/Hyperactivity Disorder in Offspring.
    Christensen J; Pedersen L; Sun Y; Dreier JW; Brikell I; Dalsgaard S
    JAMA Netw Open; 2019 Jan; 2(1):e186606. PubMed ID: 30646190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
    Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
    Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of perinatal exposures on the infant: antidepressants and depression.
    Hanley GE; Oberlander TF
    Best Pract Res Clin Obstet Gynaecol; 2014 Jan; 28(1):37-48. PubMed ID: 24100223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.